AVROBIO, Inc.
COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS

Last updated:

Abstract:

Described herein are methods for treating a subject having or at risk of developing a neurocognitive disorder, such as frontotemporal lobar degeneration or neuronal ceroid lipofuscinosis, by administering cells that contain a transgene encoding a progranulin (PGRN) or a granulin (GRN) or cells that express the PGRN or the GRN to the subject. Also disclosed are compositions comprising cells containing the transgene encoding the PGRN or the GRN.

Status:
Application
Type:

Utility

Filling date:

31 Jan 2020

Issue date:

14 Apr 2022